$1.3 Billion is the total value of Eversept Partners, LP's 86 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 42.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CYH | Buy | COMMUNITY HEALTH SYS INC NEW | $84,594,060 | -0.5% | 7,126,711 | +11.5% | 6.50% | +19.6% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $76,438,048 | +76.0% | 644,666 | +104.6% | 5.87% | +111.6% |
| GSK | Buy | GLAXOSMITHKLINE PLCcall | $67,679,172 | +2.1% | 1,553,700 | +3.3% | 5.20% | +22.7% |
| QQQ | Sell | INVESCO QQQ TRput | $65,257,200 | -42.8% | 180,000 | -37.2% | 5.01% | -31.2% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $64,171,682 | -28.6% | 609,939 | -26.8% | 4.93% | -14.1% |
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $55,533,447 | +121.8% | 1,259,162 | +122.0% | 4.26% | +166.5% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $52,429,702 | -38.1% | 292,234 | -25.4% | 4.03% | -25.6% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $49,440,747 | -10.6% | 745,263 | -21.5% | 3.80% | +7.5% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $48,959,306 | -9.8% | 417,172 | +3.3% | 3.76% | +8.4% |
| DHR | Sell | DANAHER CORPORATION | $46,903,529 | -16.2% | 159,768 | -6.0% | 3.60% | +0.7% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $38,908,423 | +111.1% | 4,143,602 | +80.0% | 2.99% | +153.7% |
| AZN | ASTRAZENECA PLCcall | $37,966,382 | +13.9% | 572,300 | 0.0% | 2.92% | +36.9% | |
| RCM | Buy | R1 RCM INC | $36,433,901 | +95.0% | 1,361,506 | +85.7% | 2.80% | +134.3% |
| AVTR | Sell | AVANTOR INC | $33,658,746 | -29.0% | 995,232 | -11.6% | 2.58% | -14.7% |
| MASI | New | MASIMO CORP | $30,413,494 | – | 208,970 | +100.0% | 2.34% | – |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $29,544,677 | -17.1% | 8,980,145 | -15.1% | 2.27% | -0.3% |
| BIIB | New | BIOGEN INCcall | $29,484,000 | – | 140,000 | +100.0% | 2.26% | – |
| HCA | Buy | HCA HEALTHCARE INC | $27,929,093 | +121.4% | 111,440 | +127.0% | 2.14% | +166.1% |
| NVST | Sell | ENVISTA HOLDINGS CORPORATION | $27,733,087 | -27.5% | 569,351 | -33.0% | 2.13% | -12.9% |
| AMRX | Sell | AMNEAL PHARMACEUTICALS INC | $22,899,542 | -25.8% | 5,491,497 | -14.7% | 1.76% | -10.8% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $21,677,589 | -5.3% | 636,453 | +7.4% | 1.66% | +13.9% |
| ARKG | Sell | ARK ETF TRgenomic rev etf | $21,610,341 | -46.9% | 470,506 | -29.2% | 1.66% | -36.2% |
| FATE | Buy | FATE THERAPEUTICS INC | $17,681,407 | +18.6% | 456,059 | +79.0% | 1.36% | +42.6% |
| BIIB | Buy | BIOGEN INC | $16,427,432 | +107.2% | 78,003 | +136.1% | 1.26% | +149.2% |
| MCK | Sell | MCKESSON CORP | $16,071,892 | -52.6% | 52,375 | -61.5% | 1.23% | -43.0% |
| ANTM | Sell | ANTHEM INC | $15,940,580 | +0.3% | 32,451 | -5.4% | 1.22% | +20.5% |
| DXCM | Buy | DEXCOM INC | $14,531,486 | +322.8% | 28,404 | +343.7% | 1.12% | +407.3% |
| GH | Buy | GUARDANT HEALTH INC | $14,122,567 | +40.7% | 213,203 | +112.5% | 1.08% | +69.1% |
| IQV | Buy | IQVIA HLDGS INC | $13,773,180 | +98.3% | 59,570 | +142.0% | 1.06% | +138.3% |
| ILMN | New | ILLUMINA INC | $13,542,395 | – | 38,759 | +100.0% | 1.04% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $12,534,342 | +91.5% | 410,021 | +95.7% | 0.96% | +130.1% |
| ICLR | Sell | ICON PLC | $11,386,588 | -29.1% | 46,816 | -9.7% | 0.87% | -14.8% |
| CNC | Sell | CENTENE CORP DEL | $10,032,922 | -45.8% | 119,170 | -46.9% | 0.77% | -34.9% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $9,995,351 | -30.1% | 37,910 | -16.7% | 0.77% | -16.0% |
| LQDA | Sell | LIQUIDIA CORPORATION | $9,890,378 | +40.3% | 1,377,490 | -4.9% | 0.76% | +68.7% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $9,754,151 | -13.1% | 280,695 | +5.6% | 0.75% | +4.5% |
| HQY | Sell | HEALTHEQUITY INC | $9,720,802 | -34.1% | 144,140 | -56.8% | 0.75% | -20.8% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $9,529,572 | +5.0% | 220,286 | +21.6% | 0.73% | +26.2% |
| QGEN | Buy | QIAGEN NV | $9,442,251 | +4.5% | 192,699 | +18.6% | 0.72% | +25.6% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $8,633,306 | -27.5% | 52,871 | -24.7% | 0.66% | -12.9% |
| OCDX | Sell | ORTHO CLINICAL DIAGNOSTICS H | $8,304,801 | -56.2% | 445,059 | -49.8% | 0.64% | -47.3% |
| ARGX | Buy | ARGENX SEsponsored adr | $7,296,904 | -3.1% | 23,142 | +7.7% | 0.56% | +16.4% |
| RGEN | Buy | REPLIGEN CORP | $6,869,235 | +465.8% | 36,521 | +696.7% | 0.53% | +575.6% |
| SYNH | Sell | SYNEOS HEALTH INCcl a | $6,590,625 | -25.0% | 81,416 | -4.9% | 0.51% | -10.0% |
| EWT | New | ISHARES INCput | $6,145,000 | – | 100,000 | +100.0% | 0.47% | – |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $5,882,174 | -49.8% | 158,806 | -58.7% | 0.45% | -39.6% |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $4,622,628 | -12.9% | 100,187 | +58.6% | 0.36% | +4.7% |
| EXEL | Sell | EXELIXIS INC | $4,605,547 | -53.0% | 203,156 | -62.1% | 0.35% | -43.5% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $4,259,091 | -50.5% | 27,047 | -63.0% | 0.33% | -40.5% |
| MASS | New | 908 DEVICES INC | $4,128,002 | – | 217,149 | +100.0% | 0.32% | – |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $4,102,992 | +20.7% | 1,424,650 | +27.4% | 0.32% | +45.2% |
| MRK | MERCK & CO INCcall | $3,995,835 | +7.1% | 48,700 | 0.0% | 0.31% | +29.0% | |
| GOSS | Buy | GOSSAMER BIO INC | $3,252,596 | +620.6% | 374,723 | +838.9% | 0.25% | +762.1% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $2,879,688 | -25.1% | 155,743 | -20.0% | 0.22% | -10.2% |
| ANAB | Sell | ANAPTYSBIO INC | $2,824,442 | -55.5% | 114,165 | -37.5% | 0.22% | -46.4% |
| RDUS | New | RADIUS HEALTH INC | $2,668,179 | – | 302,172 | +100.0% | 0.20% | – |
| PGNY | PROGYNY INCput | $2,570,000 | +2.1% | 50,000 | 0.0% | 0.20% | +22.4% | |
| New | AADI BIOSCIENCE INC | $2,559,364 | – | 150,817 | +100.0% | 0.20% | – | |
| A | Sell | AGILENT TECHNOLOGIES INC | $2,548,014 | -17.9% | 19,255 | -0.9% | 0.20% | -1.0% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $2,462,614 | -30.2% | 8,163 | -16.9% | 0.19% | -16.4% |
| MRUS | Buy | MERUS N V | $2,031,888 | +236.3% | 76,849 | +304.5% | 0.16% | +300.0% |
| KRTX | KARUNA THERAPEUTICS INC | $2,020,272 | -3.2% | 15,934 | 0.0% | 0.16% | +16.5% | |
| MRK | Sell | MERCK & CO INC | $1,986,583 | -60.5% | 9,483 | -51.3% | 0.15% | -52.3% |
| PKI | Sell | PERKINELMER INC | $1,707,614 | -72.5% | 9,788 | -68.3% | 0.13% | -66.9% |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $1,549,322 | -25.7% | 371,540 | -7.5% | 0.12% | -10.5% |
| KOD | New | KODIAK SCIENCES INCput | $1,398,864 | – | 181,200 | +100.0% | 0.11% | – |
| MIST | MILESTONE PHARMACEUTICALS IN | $944,799 | -2.0% | 147,165 | 0.0% | 0.07% | +17.7% | |
| ENSG | ENSIGN GROUP INC | $936,406 | +7.2% | 10,397 | 0.0% | 0.07% | +28.6% | |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDcall | $872,331 | -88.7% | 92,900 | -90.3% | 0.07% | -86.4% |
| HSKA | Buy | HESKA CORP | $807,002 | -2.3% | 5,836 | +29.0% | 0.06% | +17.0% |
| KOD | New | KODIAK SCIENCES INC | $704,064 | – | 91,200 | +100.0% | 0.05% | – |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $576,800 | -20.1% | 280,000 | -9.7% | 0.04% | -4.3% |
| SPRO | New | SPERO THERAPEUTICS INC | $518,859 | – | 59,639 | +100.0% | 0.04% | – |
| CSU | SONIDA SENIOR LIVING INC | $503,874 | +16.3% | 15,209 | 0.0% | 0.04% | +39.3% | |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $488,397 | -62.7% | 237,086 | -32.0% | 0.04% | -54.8% |
| ACIU | Sell | AC IMMUNE SA | $498,356 | -34.4% | 124,589 | -18.8% | 0.04% | -22.4% |
| SRGA | Sell | SURGALIGN HOLDINGS INC | $478,908 | -65.2% | 1,573,802 | -18.0% | 0.04% | -58.0% |
| TECH | New | BIO-TECHNE CORP | $459,888 | – | 1,062 | +100.0% | 0.04% | – |
| ELDN | ELEDON PHARMACEUTICALS INC | $449,192 | -10.7% | 114,008 | 0.0% | 0.03% | +6.2% | |
| IWO | Sell | ISHARES TRput | $434,775 | -98.4% | 1,700 | -98.1% | 0.03% | -98.0% |
| CYCN | CYCLERION THERAPEUTICS INC | $412,870 | -35.5% | 371,955 | 0.0% | 0.03% | -22.0% | |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $414,590 | -0.1% | 370,170 | +42.7% | 0.03% | +18.5% |
| AVRO | Sell | AVROBIO INC | $389,887 | -66.8% | 295,369 | -3.2% | 0.03% | -60.0% |
| ORTX | ORCHARD THERAPEUTICS PLCads | $298,742 | -46.1% | 419,581 | 0.0% | 0.02% | -34.3% | |
| GLYC | Buy | GLYCOMIMETICS INC | $114,660 | -20.4% | 100,579 | +0.6% | 0.01% | 0.0% |
| CLVS | New | CLOVIS ONCOLOGY INC | $60,600 | – | 30,000 | +100.0% | 0.01% | – |
| MNKD | Exit | MANNKIND CORPcall | $0 | – | -50,000 | -100.0% | -0.01% | – |
| FSTX | Exit | F-STAR THERAPEUTICS INC | $0 | – | -49,933 | -100.0% | -0.02% | – |
| JYNT | Exit | JOINT CORPput | $0 | – | -5,500 | -100.0% | -0.02% | – |
| BKD | Exit | BROOKDALE SR LIVING INC | $0 | – | -79,146 | -100.0% | -0.03% | – |
| LOGC | Exit | LOGICBIO THERAPEUTICS INC | $0 | – | -291,101 | -100.0% | -0.04% | – |
| VCRA | Exit | VOCERA COMMUNICATIONS INC | $0 | – | -14,970 | -100.0% | -0.06% | – |
| MYO | Exit | MYOMO INC | $0 | – | -150,000 | -100.0% | -0.07% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DELcall | $0 | – | -7,600 | -100.0% | -0.10% | – |
| ESTA | Exit | ESTABLISHMENT LABS HLDGS INC | $0 | – | -25,137 | -100.0% | -0.11% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -38,672 | -100.0% | -0.12% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCcall | $0 | – | -84,600 | -100.0% | -0.13% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -14,840 | -100.0% | -0.14% | – |
| GRTS | Exit | GRITSTONE BIO INC | $0 | – | -170,125 | -100.0% | -0.14% | – |
| CVAC | Exit | CUREVAC N V | $0 | – | -85,017 | -100.0% | -0.19% | – |
| LXRX | Exit | LEXICON PHARMACEUTICALS INC | $0 | – | -797,694 | -100.0% | -0.20% | – |
| MRVI | Exit | MARAVAI LIFESCIENCES HLDGS I | $0 | – | -87,795 | -100.0% | -0.24% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -201,384 | -100.0% | -0.29% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -66,074 | -100.0% | -0.34% | – |
| SIBN | Exit | SI-BONE INC | $0 | – | -258,094 | -100.0% | -0.37% | – |
| CERN | Exit | CERNER CORP | $0 | – | -77,543 | -100.0% | -0.46% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB Lcall | $0 | – | -70,000 | -100.0% | -0.48% | – |
| PODD | Exit | INSULET CORP | $0 | – | -30,172 | -100.0% | -0.51% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -550,966 | -100.0% | -0.57% | – |
| NTRA | Exit | NATERA INC | $0 | – | -102,071 | -100.0% | -0.61% | – |
| MGLN | Exit | MAGELLAN HEALTH INC | $0 | – | -104,700 | -100.0% | -0.64% | – |
| ARKK | Exit | ARK ETF TRinnovation etf | $0 | – | -119,118 | -100.0% | -0.72% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -231,787 | -100.0% | -0.78% | – |
| HUM | Exit | HUMANA INC | $0 | – | -27,382 | -100.0% | -0.81% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -113,800 | -100.0% | -0.81% | – |
| ARKG | Exit | ARK ETF TRcall | $0 | – | -243,800 | -100.0% | -0.95% | – |
| CYH | Exit | COMMUNITY HEALTH SYS INC NEWcall | $0 | – | -1,277,200 | -100.0% | -1.09% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -94,100 | -100.0% | -1.32% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -125,000 | -100.0% | -1.78% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.